New injection aims to shed fluid in heart failure patients
NCT ID NCT07318103
First seen Jan 07, 2026 · Last updated May 22, 2026 · Updated 25 times
Summary
This study tests an injectable drug called HRS-9057 in adults hospitalized with heart failure who have fluid retention. The main goal is to see if it helps reduce weight (a sign of fluid loss) by day 8 compared to a placebo. About 153 participants will receive either the drug or a placebo, and researchers will also monitor safety and the need for additional diuretics.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FLUID RETENTION CAUSED BY HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fuwai Hospital, Chinese Academy of Medical Sciences
RECRUITINGBeijing, Beijing Municipality, 100037, China
Contact
Conditions
Explore the condition pages connected to this study.